- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16:42 | BMS 1Q: Opdivo Sales Down 10%, Announces Restructuring Initiative | ||
| 16:42 | Pfizer's BEQVEZ Approved by FDA for Treatment of Adults with Hemophilia B | ||
| 16:42 | Abzena Introduces Enhanced Bioassay Platform | ||
| Do | Fujifilm & Predictive Oncology Tackle Protein Interference | ||
| Do | Regeneron & Mammoth Partner on CRISPR Therapies | ||
| Do | FDA Approves Utility Therapeutics' Pivya in UTIs | ||
| Do | Actym Therapeutics Taps Industry Veteran as CEO | ||
| Do | Multiply Labs and GenScript Partner to Automate Cell Isolation | ||
| Do | Parexel, Palantir Expand AI Alliance | ||
| Do | Ascend Taps Scott Law as COO | ||
| Do | FibroBiologics Discusses Opportunities to Work with Charles River | ||
| Mi | Lilly Acquires Manufacturing Facility from Nexus Pharmaceuticals | ||
| Mi | Kühne Holding AG Agrees to Acquire Aenova Group | ||
| Mi | BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design | ||
| Mi | Moderna and OpenAI Join Forces to Transform Healthcare with AI | ||
| Mi | CureVac Names New Chief Business Officer | ||
| Mi | Hanmi, Merck Enter Clinical Collaboration & Supply Agreement | ||
| Mi | Tetra Pharm Technologies & Glysious Partner to Develop Transdermal Combination Drugs | ||
| Di | Evotec Appoints Dr. Christian Wojczewski CEO | ||
| Di | Sanofi's Rilzabrutinib Meets Primary Endpoint in ITP | ||
| Di | Sygnature Discovery Names New Chief Scientific Officer | ||
| Di | Particle Dynamics Names New Chief Financial Officer | ||
| Di | SnapSlide Introduces No-Torque, Child-Resistant Caps | ||
| Di | Tharimmune Announces Option for Novel HER2/HER3 Cancer Therapies | ||
| Di | Vertex Obtains Exclusive License to TreeFrog's C-Stem Technology |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
